321 related articles for article (PubMed ID: 34868907)
1. A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy.
Mao C; Ding Y; Xu N
Front Oncol; 2021; 11():688489. PubMed ID: 34868907
[TBL] [Abstract][Full Text] [Related]
2. GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.
Kumar A; Taghi Khani A; Sanchez Ortiz A; Swaminathan S
Front Immunol; 2022; 13():901277. PubMed ID: 35865534
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.
Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z
Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment.
Sun BL
Prostate; 2021 Nov; 81(15):1125-1134. PubMed ID: 34435699
[TBL] [Abstract][Full Text] [Related]
5. Immunodiagnostics and Immunotherapy Possibilities for Prostate Cancer.
Schatten H
Adv Exp Med Biol; 2018; 1096():185-194. PubMed ID: 30324354
[TBL] [Abstract][Full Text] [Related]
6. Immune Cell-Conditioned Media Suppress Prostate Cancer PC-3 Cell Growth Correlating With Decreased Proinflammatory/Anti-inflammatory Cytokine Ratios in the Media Using 5 Selected Crude Polysaccharides.
Lin HC; Lin JY
Integr Cancer Ther; 2016 Dec; 15(4):NP13-NP25. PubMed ID: 27130724
[TBL] [Abstract][Full Text] [Related]
7. Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy.
Chulpanova DS; Kitaeva KV; Green AR; Rizvanov AA; Solovyeva VV
Front Cell Dev Biol; 2020; 8():402. PubMed ID: 32582698
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
9. Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer.
Ollivier L; Labbé M; Fradin D; Potiron V; Supiot S
Front Oncol; 2021; 11():744679. PubMed ID: 34595122
[TBL] [Abstract][Full Text] [Related]
10. The relationship between autophagy and the immune system and its applications for tumor immunotherapy.
Jiang GM; Tan Y; Wang H; Peng L; Chen HT; Meng XJ; Li LL; Liu Y; Li WF; Shan H
Mol Cancer; 2019 Jan; 18(1):17. PubMed ID: 30678689
[TBL] [Abstract][Full Text] [Related]
11. Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.
Chiriva-Internati M; Yu Y; Mirandola L; D'Cunha N; Hardwicke F; Cannon MJ; Cobos E; Kast WM
Prostate; 2012 Jan; 72(1):12-23. PubMed ID: 21520158
[TBL] [Abstract][Full Text] [Related]
12. IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.
Kourko O; Seaver K; Odoardi N; Basta S; Gee K
Front Oncol; 2019; 9():969. PubMed ID: 31681561
[TBL] [Abstract][Full Text] [Related]
13. Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
Martori C; Sanchez-Moral L; Paul T; Pardo JC; Font A; Ruiz de Porras V; Sarrias MR
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053602
[TBL] [Abstract][Full Text] [Related]
14. Role of cytokines as a double-edged sword in sepsis.
Chaudhry H; Zhou J; Zhong Y; Ali MM; McGuire F; Nagarkatti PS; Nagarkatti M
In Vivo; 2013; 27(6):669-84. PubMed ID: 24292568
[TBL] [Abstract][Full Text] [Related]
15. Immunological Complexity of the Prostate Cancer Microenvironment Influences the Response to Immunotherapy.
Prokhnevska N; Emerson DA; Kissick HT; Redmond WL
Adv Exp Med Biol; 2019; 1210():121-147. PubMed ID: 31900908
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment.
Mahmood J; Shukla HD; Soman S; Samanta S; Singh P; Kamlapurkar S; Saeed A; Amin NP; Vujaskovic Z
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30486519
[TBL] [Abstract][Full Text] [Related]
17. Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines.
Essogmo FE; Zhilenkova AV; Tchawe YSN; Owoicho AM; Rusanov AS; Boroda A; Pirogova YN; Sangadzhieva ZD; Sanikovich VD; Bagmet NN; Sekacheva MI
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001643
[TBL] [Abstract][Full Text] [Related]
18. Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction.
Guo J; Zhao J; Sun L; Yang C
Front Oncol; 2022; 12():955718. PubMed ID: 35924159
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer immunotherapy.
Mitsogiannis I; Tzelves L; Dellis A; Issa H; Papatsoris A; Moussa M
Expert Opin Biol Ther; 2022 May; 22(5):577-590. PubMed ID: 35037527
[TBL] [Abstract][Full Text] [Related]
20. Signaling new therapeutic opportunities: cytokines in prostate cancer.
Chandran E; Meininger L; Karzai F; Madan RA
Expert Opin Biol Ther; 2022 Oct; 22(10):1233-1243. PubMed ID: 35930001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
